SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC
http://www.w3.org/2000/01/rdf-schema#comment
"increase of cell proliferation after adenosine A(3) receptor agonist IB-MECA treatment irrespective of the cell lineage investigated"
xsd:string
http://purl.uniprot.org/uniprot/#_56DA15181C252614992E198EDA2D4ED94794884ACC6F108684A1E997498C27D6DF88C5C0379D687C17562D1482859597
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC
http://purl.uniprot.org/uniprot/Q3U4C5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC
http://purl.uniprot.org/uniprot/#_Q3U4C5-mappedCitation-17383145
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D18D4BCB6B22BB5C9D45A073BD53340EA169986021C7370A115211596398BF225CAAE681CB6829ABFB6F697C76279BBC